Target Name: CCNT2
NCBI ID: G905
Other Name(s): Cyclin T2b | SDS-stable vimentin-bound DNA fragment HEF42VIM22 | Cyclin T2a | Cyclin-T2 | CYCT2 | cyclin T2a | Subunit of positive elongation transcription factor b | cyclin T2 | cyclin T2b | Cyclin T2, transcript variant b | CCNT2 variant b | CCNT2_HUMAN | CycT2 | subunit of positive elongation transcription factor b

Exploring The Potential Role of CCNT2 as A Drug Target and Biomarker

Cyclin T2b (CCNT2) is a protein that is expressed in a variety of tissues throughout the body, including the brain, heart, and gastrointestinal tract. It is a key regulator of cell proliferation and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Despite its widespread expression, the precise function of CCNT2 is not well understood, and it has not been fully characterized as a drug target or biomarker. In this article, we will explore the potential role of CCNT2 as a drug target and highlight its potential as a biomarker for a variety of diseases.

Disease-Related Role of CCNT2

The precise function of CCNT2 is not well understood, but it is involved in a number of processes that are important for normal cellular function. One of its most well-studied functions is its role in cell proliferation. CCNT2 has been shown to play a key role in regulating cell cycle progression, and it has been shown to interact with several other proteins that are involved in cell proliferation, including the transcription factor, p21.

In addition to its role in cell proliferation, CCNT2 is also involved in several other processes that are important for normal cellular function. For example, it has been shown to play a key role in the regulation of cell adhesion, and it has been shown to interact with the protein, cadherin. Additionally, CCNT2 has been shown to play a key role in the regulation of cell migration, and it has been shown to interact with the protein, vimentin.

Potential Therapeutic Applications of CCNT2

The potential therapeutic applications of CCNT2 are vast, and there is growing interest in using it as a drug target or biomarker for a variety of diseases. One of the most promising applications of CCNT2 is its potential as a therapeutic target for cancer. CCNT2 has been shown to play a key role in the regulation of cell proliferation, and it has been shown to interact with several proteins that are involved in cancer cell growth and survival. As a result, CCNT2 has been shown to be a promising target for cancer therapies that target cell proliferation.

In addition to its potential as a cancer therapeutic, CCNT2 has also been shown to have potential applications as a biomarker for a variety of diseases. For example, CCNT2 has been shown to be expressed in a variety of tissues and has been shown to play a key role in the regulation of cellular processes that are important for normal disease progression. As a result, CCNT2 has been shown to have potential as a biomarker for a variety of diseases, including neurodegenerative diseases and autoimmune disorders.

Current Research on CCNT2

While the potential therapeutic applications of CCNT2 are vast, the precise function of the protein are not well understood. As a result, there is ongoing research to fully characterize its functions and to identify new potential targets for therapeutic intervention.

One of the most promising areas of research on CCNT2 is its potential as a therapeutic target for cancer. Researchers are working to identify the precise mechanisms by which CCNT2 promotes cancer cell growth and survival, and to develop strategies for targeting it as a therapeutic intervention. Additionally, researchers are working to identify new potential biomarkers for cancer that can be used to monitor the effectiveness of cancer therapies.

Conclusion

In conclusion, CCNT2 is a protein that is widely expressed in a variety of tissues throughout the body and has been implicated in a number of diseases. Despite its widespread expression, the precise function of CCNT2 is not well understood, and there is ongoing research to fully characterize its functions and to identify new potential targets for therapeutic intervention. The potential therapeutic applications of CCNT2 are vast, and there is growing interest in using it as a drug

Protein Name: Cyclin T2

Functions: Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II) (PubMed:9499409, PubMed:15563843). The activity of this complex is regulated by binding with 7SK snRNA (PubMed:11713533). Plays a role during muscle differentiation; P-TEFB complex interacts with MYOD1; this tripartite complex promotes the transcriptional activity of MYOD1 through its CDK9-mediated phosphorylation and binds the chromatin of promoters and enhancers of muscle-specific genes; this event correlates with hyperphosphorylation of the CTD domain of RNA pol II (By similarity). In addition, enhances MYOD1-dependent transcription through interaction with PKN1 (PubMed:16331689). Involved in early embryo development (By similarity)

More Common Targets

CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2 | CCP110 | CCPG1 | CCR1 | CCR10 | CCR12P | CCR2 | CCR3 | CCR4 | CCR4-NOT transcription complex | CCR5 | CCR5AS | CCR6 | CCR7 | CCR8 | CCR9 | CCRL2 | CCS | CCSAP | CCSER1 | CCSER2 | CCT2 | CCT3 | CCT4 | CCT5 | CCT6A | CCT6B | CCT6P1 | CCT6P3 | CCT7 | CCT8 | CCT8L1P | CCT8L2 | CCT8P1 | CCZ1 | CCZ1B | CCZ1P-OR7E38P | CD101 | CD101-AS1 | CD109 | CD14 | CD151 | CD160 | CD163 | CD163L1 | CD164 | CD164L2 | CD177 | CD177P1 | CD180 | CD19 | CD1A | CD1B | CD1C | CD1D | CD1E | CD2 | CD200 | CD200R1 | CD200R1L | CD207 | CD209 | CD22 | CD226 | CD24 | CD244 | CD247 | CD248 | CD24P2 | CD27 | CD27-AS1 | CD274 | CD276 | CD28 | CD2AP | CD2BP2 | CD3 Complex (T Cell Receptor Complex) | CD300A | CD300C | CD300E | CD300LB | CD300LD | CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4